HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoki Sakurai Selected Research

Bispecific Antibodies

4/2002Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies.
3/2002A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoki Sakurai Research Topics

Disease

6Neoplasms (Cancer)
03/2015 - 03/2002
4Neoplasm Metastasis (Metastasis)
03/2015 - 02/2007
3Carcinoma (Carcinomatosis)
03/2015 - 03/2002
2Adenocarcinoma
05/2022 - 01/2022
2Cholangiocarcinoma
11/2021 - 07/2010
2Stroke (Strokes)
04/2006 - 06/2005
1Chylothorax
08/2022
1Histiocytic Sarcoma
05/2022
1Adrenocortical Carcinoma
05/2022
1Adrenocortical Adenoma (Disease, Conn's)
05/2022
1Hepatocellular Carcinoma (Hepatoma)
05/2022
1Hyperplasia
05/2022
1Polyps
05/2022
1Follicular Adenocarcinoma
05/2022
1Adenoma (Adenomas)
05/2022
1Pheochromocytoma
05/2022
1Liver Cell Adenoma (Hepatocellular Adenoma)
05/2022
1Fever (Fevers)
03/2015
1Mycoses (Diseases, Fungus)
02/2015
1Malnutrition (Nutritional Deficiencies)
01/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2011
1Hypersensitivity (Allergy)
05/2009
1Colorectal Neoplasms (Colorectal Cancer)
01/2009
1Liver Diseases (Liver Disease)
01/2009
1Paraproteinemias (Monoclonal Gammopathy)
11/2007
1Necrobiotic Xanthogranuloma
11/2007
1Breast Neoplasms (Breast Cancer)
03/2007
1Dermatomyositis (Dermatopolymyositis)
03/2007

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
03/2015 - 02/2015
2Bispecific AntibodiesIBA
04/2002 - 03/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
11/2021
1titanium silicide (TS-1)IBA
03/2015
1Polysaccharides (Glycans)IBA
02/2015
1hemicelluloseIBA
02/2015
1GemcitabineFDA Link
01/2012
1Cholecalciferol (Vitamin D3)FDA Link
07/2011
1Tumor Biomarkers (Tumor Markers)IBA
07/2010
1Paclitaxel (Taxol)FDA LinkGeneric
07/2010
1Carbamazepine (Tegretol)FDA LinkGeneric
05/2009
1Prednisolone (Predate)FDA LinkGeneric
11/2007
1Melphalan (Alkeran)FDA LinkGeneric
11/2007
1SteroidsIBA
03/2007
1Imatinib Mesylate (Gleevec)FDA Link
02/2007
1Indicators and Reagents (Reagents)IBA
03/2002
1Interleukin-2 (IL2)IBA
03/2002
1SuperantigensIBA
03/2002

Therapy/Procedure

4Therapeutics
01/2022 - 04/2002
2Pancreaticoduodenectomy
03/2015 - 07/2010
2Drug Therapy (Chemotherapy)
03/2015 - 07/2010
2Hepatectomy
01/2009 - 02/2007
2Immunotherapy
04/2002 - 03/2002
1Ligation
08/2022
1Pericardiectomy
08/2022
1Prostatectomy (Retropubic Prostatectomy)
01/2022
1Aftercare (After-Treatment)
03/2015
1Adjuvant Chemotherapy
01/2012
1Neoadjuvant Therapy
01/2012
1Pancreatectomy
01/2012
1Phototherapy (Light Therapy)
07/2011
1Esophagectomy
02/2007
1Dentures
04/2006
1Bite Force (Occlusal Forces)
06/2005